diabetes mellitus, type 2

Showing NaN - NaN of 83

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart 30, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart 30
  • +2 more
  • Broadmeadow, New South Wales, Australia
  • +40 more
Sep 6, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +2 more
  • Glendale, Arizona
  • +143 more
Jan 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, biphasic insulin aspart 30)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • biphasic insulin aspart 30
  • St Leonards, New South Wales, Australia
  • +52 more
Nov 30, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in India (therapy regimen)

Completed
  • Diabetes Mellitus, Type 2
  • therapy regimen
  • Gopalapuram, Chennai, India
  • +10 more
Nov 8, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, biphasic insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • biphasic insulin aspart
  • Algiers, Algeria
  • +31 more
Dec 20, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (insulin aspart, inhaled human insulin)

Terminated
  • Diabetes
  • +3 more
  • insulin aspart
  • inhaled human insulin
  • Fresno, California
  • +31 more
Sep 3, 2018

(PMS) Study of Ryzodeg™ in Diabetes Mellitus in Routine Clinical

Completed
  • Diabetes
  • +2 more
  • insulin degludec/insulin aspart
  • Guntur, Andhra Pradesh, India
  • +34 more
Mar 12, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +301 more
Feb 16, 2018

Diabetes, Type 2 Trial in Worldwide (GSK189075, pioglitazone, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +135 more
Nov 2, 2017

Diabetes, Type 2 Trial in Worldwide (GSK189075, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Mesa, Arizona
  • +156 more
Sep 26, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • placebo
  • Anaheim, California
  • +86 more
Sep 26, 2017

Diabetes, Type 2 Trial in Worldwide (LY2963016, LANTUS®, Oral Antihyperglycemic Medication)

Completed
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +43 more
Sep 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, metformin, sulphonylurea)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Algiers, Algeria
  • +40 more
Jul 25, 2017

A Non-interventional, Post Marketing Surveillance Study of

Completed
  • Diabetes
  • +2 more
  • insulin degludec
  • Guntur, Andhra Pradesh, India
  • +37 more
Aug 1, 2017

Diabetes, Type 2 Trial in Worldwide (pioglitazone, rosiglitazone, )

Terminated
  • Diabetes Mellitus, Type 2
  • Long Beach, California
  • +330 more
Mar 21, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +85 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in China, India, Korea, Republic of (liraglutide, , glimepiride)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Beijing, Beijing, China
  • +49 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, metformin, glimepiride)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ciudad Autonoma de Bs As, Argentina
  • +189 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, sitagliptin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +92 more
Jan 19, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin glargine, insulin degludec, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin glargine
  • +2 more
  • Inglewood, California
  • +28 more
Jan 19, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (inhaled human insulin, insulin aspart)

Terminated
  • Diabetes
  • +3 more
  • inhaled human insulin
  • insulin aspart
  • Buenos Aires, Argentina
  • +26 more
Feb 28, 2017

Diabetes, Type 2 Trial in Worldwide (albiglutide, sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +217 more
Jan 16, 2017